GlaxoSmithKline (GSK - Egypt) received a letter from Arab Company For Drugs Industries & Medical Appliances (ACDIMA Egypt) expressing its interest in acquiring the majority shareholder’s stake, according to a statement filed to the Egyptian Exchange.

Earlier, Hikma Pharmaceuticals intends to buy Glaxo Group's 91.2% stake in GSK - Egypt.

It worth mentioning that the company announced its plans for a merger with its subsidiary Amoun Pharmaceutical Company.

GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacture, packaging, marketing, sale, and distribution of pharmaceutical products.